chr5-140114302-G-GGCGGCA
Position:
Variant summary
Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP6_Very_StrongBS2
The NM_005859.5(PURA):c.123_128dupCGGCAG(p.Ser43_Gly44insGlySer) variant causes a disruptive inframe insertion change. The variant allele was found at a frequency of 0.000195 in 1,278,846 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Genomes: 𝑓 0.000054 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00021 ( 0 hom. )
Consequence
PURA
NM_005859.5 disruptive_inframe_insertion
NM_005859.5 disruptive_inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 5.66
Genes affected
PURA (HGNC:9701): (purine rich element binding protein A) This gene product is a sequence-specific, single-stranded DNA-binding protein. It binds preferentially to the single strand of the purine-rich element termed PUR, which is present at origins of replication and in gene flanking regions in a variety of eukaryotes from yeasts through humans. Thus, it is implicated in the control of both DNA replication and transcription. Deletion of this gene has been associated with myelodysplastic syndrome and acute myelogenous leukemia. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -12 ACMG points.
BP6
Variant 5-140114302-G-GGCGGCA is Benign according to our data. Variant chr5-140114302-G-GGCGGCA is described in ClinVar as [Likely_benign]. Clinvar id is 436450.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 8 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PURA | NM_005859.5 | c.123_128dupCGGCAG | p.Ser43_Gly44insGlySer | disruptive_inframe_insertion | 1/1 | ENST00000331327.5 | NP_005850.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PURA | ENST00000331327.5 | c.123_128dupCGGCAG | p.Ser43_Gly44insGlySer | disruptive_inframe_insertion | 1/1 | 6 | NM_005859.5 | ENSP00000332706.3 | ||
PURA | ENST00000651386.1 | c.123_128dupCGGCAG | p.Ser43_Gly44insGlySer | disruptive_inframe_insertion | 2/2 | ENSP00000499133.1 | ||||
PURA | ENST00000505703.2 | c.123_128dupCGGCAG | p.Ser43_Gly44insGlySer | disruptive_inframe_insertion | 2/2 | 3 | ENSP00000498560.1 | |||
PURA | ENST00000502351.1 | c.*42_*43insGCGGCA | downstream_gene_variant | 2 | ENSP00000498760.1 |
Frequencies
GnomAD3 genomes AF: 0.0000536 AC: 8AN: 149370Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
8
AN:
149370
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.000213 AC: 241AN: 1129476Hom.: 0 Cov.: 31 AF XY: 0.000189 AC XY: 103AN XY: 545716
GnomAD4 exome
AF:
AC:
241
AN:
1129476
Hom.:
Cov.:
31
AF XY:
AC XY:
103
AN XY:
545716
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000536 AC: 8AN: 149370Hom.: 0 Cov.: 32 AF XY: 0.0000550 AC XY: 4AN XY: 72744
GnomAD4 genome
AF:
AC:
8
AN:
149370
Hom.:
Cov.:
32
AF XY:
AC XY:
4
AN XY:
72744
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 07, 2016 | - - |
PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 11, 2024 | - - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Oct 16, 2021 | In-frame insertion in a repetitive region with no known function; Has not been previously published as pathogenic or benign to our knowledge - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at